Moleculin Biotech Statistics

Total Valuation

MBRX has a market cap or net worth of $13.43 million. The enterprise value is $9.63 million.

Market Cap	13.43M
Enterprise Value	9.63M

Important Dates

The next estimated earnings date is Friday, May 9, 2025, after market close.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

MBRX has 14.00 million shares outstanding. The number of shares has increased by 74.28% in one year.

Current Share Class	14.00M
Shares Outstanding	14.00M
Shares Change (YoY)	+74.28%
Shares Change (QoQ)	+35.68%
Owned by Insiders (%)	1.07%
Owned by Institutions (%)	3.48%
Float	13.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.54
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.08.

Current Ratio	0.97
Quick Ratio	0.80
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -135.80% and return on invested capital (ROIC) is -100.60%.

Return on Equity (ROE)	-135.80%
Return on Assets (ROA)	-60.39%
Return on Invested Capital (ROIC)	-100.60%
Return on Capital Employed (ROCE)	-230.34%
Revenue Per Employee	n/a
Profits Per Employee	-$1.21M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -83.30% in the last 52 weeks. The beta is 2.20, so MBRX's price volatility has been higher than the market average.

Beta (5Y)	2.20
52-Week Price Change	-83.30%
50-Day Moving Average	1.24
200-Day Moving Average	2.31
Relative Strength Index (RSI)	41.46
Average Volume (20 Days)	694,828

Short Selling Information

The latest short interest is 463,550, so 3.31% of the outstanding shares have been sold short.

Short Interest	463,550
Short Previous Month	1.08M
Short % of Shares Out	3.31%
Short % of Float	3.35%
Short Ratio (days to cover)	0.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-26.64M
Pretax Income	-26.82M
Net Income	-21.76M
EBITDA	-26.52M
EBIT	-26.64M
Earnings Per Share (EPS)	-$6.32

Full Income Statement

Balance Sheet

The company has $4.28 million in cash and $478,000 in debt, giving a net cash position of $3.80 million or $0.27 per share.

Cash & Cash Equivalents	4.28M
Total Debt	478,000
Net Cash	3.80M
Net Cash Per Share	$0.27
Equity (Book Value)	5.98M
Book Value Per Share	1.77
Working Capital	-165,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$23.86 million and capital expenditures -$13,000, giving a free cash flow of -$23.88 million.

Operating Cash Flow	-23.86M
Capital Expenditures	-13,000
Free Cash Flow	-23.88M
FCF Per Share	-$1.71

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-74.28%
Shareholder Yield	-74.28%
Earnings Yield	-162.07%
FCF Yield	-177.80%

Analyst Forecast

The average price target for MBRX is $17.33, which is 1,706.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.33
Price Target Difference	1,706.90%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 22, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Mar 22, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a